Lupin announced the launch of Moxifloxacin Ophthalmic Solution USP, 0.5%, having received an approval from the United States Food and
Read MorePharmaceutical companies that market medicines made by third parties in the country will now be held responsible for drug product
Read MoreRoche today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq® (atezolizumab), in combination with carboplatin and etoposide
Read MoreCarbiotix (publ) (“Carbiotix”) announces today that the company has launched its second generation diagnostic platform for gut health based on
Read MoreThe FDA approved and granted a priority review to the new drug application (NDA) for capmatinib (INC280), according to Novartis,
Read More